Delivery Order 75N91019D00012-75N91020F00001
Award Date
9/8/20
Potential Completion Date
9/30/25
Potential Value
$3M
Federal Agency
National Cancer Institute
Awardee
IIT Research Institute
Ultimate Awardee
Illinois Institute Of Technology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a division of the Illinois Institute of Technology, is for a $596,209 Firm Fixed Price Delivery Order under the "PREVENT Cancer Program (PREVENT)" contract vehicle. The contract is for the "NOVEL ANDROGEN RECEPTOR ANTAGONIST-MEDIATED CHEMOPREVENTION OF PROSTATE CANCER" project, which aims to conduct preclinical research to support the development of therapies for...
This federal contract award was issued by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology (IIT). The $1,405,361.18 delivery order contract supports the PREVENT Preclinical Drug Development Program, a significant $150 million multiple-award IDIQ contract with NCI. Under this task order, IITRI will provide topical resatorvid for nonmelanoma skin cancer prevention research during the period of September 2020...
This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI) to IIT Research Institute (IITRI), a non-profit preclinical contract research organization (CRO). The contract is for $532,562.26 to evaluate a breast cancer prevention agent under the PREVENT Cancer Preclinical Drug Development Program, a $149.995 million NCI Indefinite Delivery Vehicle (IDV) that IITRI holds. IITRI has extensive experience providing preclinical drug development services to federal...
This is a firm fixed price delivery order awarded by the National Cancer Institute, part of the Department of Health and Human Services National Institutes of Health, to IIT Research Institute. The order is for preclinical efficacy evaluation of a lipid-based SMEDDS formulation of the drug compound DIM, BR-9001, as part of the NCI's Preclinical Prevent Cancer Program. The $970,988.47 contract has a completion date of February 7, 2022. IIT Research Institute is a non-profit research...
This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $1,725 firm fixed price order is for a contract orientation meeting and is part of a larger $146.3 million IDIQ contract between IITRI and the National Institute of Allergy and Infectious Diseases (NIAID) for preclinical models of infectious diseases. IITRI has...
This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $23,349,236 contract is for the provision of preclinical in vitro and in vivo screening assays to support the development of cancer preventive agents. IITRI, which has extensive experience supporting the preclinical development of various therapeutics for...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $2,398.74 delivery order against the PREVENT Preclinical Drug Development Program indefinite-delivery/indefinite-quantity master contract to IIT Research Institute. IIT Research Institute, a subsidiary of the Illinois Institute Of Technology Sponsored Research And Programs Division, will provide a "CONTRACT ORIENTATION AND KICKOFF MEETING" as the prime contractor. The...
This is a delivery order issued against the Preclinical Agent Development Assays 2012-2016 contract vehicle by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to the IIT Research Institute (IITRI), a non-profit contract research organization, to conduct other functions related to preclinical in vitro and in vivo agent development assays, including an orientation meeting. The total ceiling value of...
This federal contract award with award ID HHSN261201500024I|HHSN26100003 was issued by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS). The $321,110.80 award was made on September 15, 2016 to the IIT Research Institute (IITRI), a non-profit research organization and division of the Illinois Institute of Technology (IIT).
The contract is for the "PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS" under the NCI's PREVENT...
This federal contract award, valued at $656,577.00, was issued by the National Cancer Institute (NCI) to the Illinois Institute of Technology Research Institute (IITRI), a non-profit contract research organization. The contract is a delivery order under the PREVENT Preclinical Drug Development Program, a larger NCI indefinite delivery/indefinite quantity (IDIQ) contract vehicle worth $150 million.
The task order supports nicotine reduction therapy research using the human monoclonal antibody...